title: [Atypical neuroleptics in the treatment of aggression and hostility in schizophrenic patients].
abstract: The treatment of aggressive symptoms in schizophrenic patients is a relevant clinical problem. We systematically review the efficacy of the different atypical neuroleptics on acute or persistent aggressive symptoms also regarding methodological problems. Currently typical neuroleptics are still first choice in treating acute aggressive symptoms, while risperidone and olanzapine could be alternatives. In persistent aggression clozapin shows the best specific results. Typical depot neuroleptics should be considered in cases when medication compliance is a problem.
authors.affiliation: Zentrum für psychosoziale Medizin, Psychiatrie und Psychotherapie, Universitätsklinikum Hamburg-Eppendorf, Germany. briken@uke.unij-hamburg.de
authors.forename: P
authors.initials: P
authors.lastname: Briken
authors.forename: E
authors.initials: E
authors.lastname: Nika
authors.forename: M
authors.initials: M
authors.lastname: Krausz
authors.forename: D
authors.initials: D
authors.lastname: Naber
mesh_terms: D000374:Aggression / Q000187:drug effects* / Q000523:psychology*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D003024:Clozapine / Q000627:therapeutic use; D006791:Hostility; D006801:Humans; D000077152:Olanzapine; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018967:Risperidone / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D003024:Clozapine; D018967:Risperidone; D000077152:Olanzapine